会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • TRACEABLE RETINOID ACID FOR IMAGING, DISEASE PREVENTION AND THERAPY
    • 用于成像,疾病预防和治疗的可追踪的抗感染药
    • US20120244079A1
    • 2012-09-27
    • US13319012
    • 2010-05-06
    • Shi KeMichel MawadWei Wang
    • Shi KeMichel MawadWei Wang
    • C07D403/08A61K49/04A61K49/00
    • A61K49/0052A61K49/0032G01N33/5008G01N33/5014G01N33/5088G01N33/574G01N33/582G01N2800/56
    • The present invention provides nonradioactive NIR optical imaging agents based up on the structure of retinoid acid derivatives. The nonradioactive NIR optical imaging agent has been evaluated at the cellular level by confocal microscopy, and in vivo in a whole animal using a various xenograft models. The specific uptake of this agent in human cancer cells and multiple xenograft models demonstrate that nonradioactive near infrared dye labeled retinoid metabolites and/or analogs are useful for early stage cancer studies and diagnoses. Also, the present invention provides that nonradioactive near infrared dye labeled retinoid metabolites and/or analogs are useful for visualization of drug redistribution within the body which is useful in determining the optimal biological dose. Ultimately, the visualization data can be used as an analytical tool to reduce any systemic toxicity.
    • 本发明提供了基于类视黄酸衍生物结构的非放射性近红外光学成像剂。 已经通过共聚焦显微镜在细胞水平上评估了非放射性近红外光学成像剂,并且在使用各种异种移植模型的整个动物体内进行了评估。 该药物在人类癌细胞和多种异种移植物模型中的特异性摄取表明,非放射性近红外染料标记的类视黄醇代谢物和/或类似物可用于早期癌症研究和诊断。 此外,本发明提供非放射性近红外染料标记的类视黄醇代谢物和/或类似物可用于体内药物再分布的可视化,其可用于确定最佳生物剂量。 最终,可视化数据可用作分析工具,以减少任何全身毒性。
    • 3. 发明申请
    • Microcatheter including swellable tip
    • 微导管包括可膨胀的尖端
    • US20050165379A1
    • 2005-07-28
    • US10755249
    • 2004-01-12
    • Michel Mawad
    • Michel Mawad
    • A61M29/00A61M31/00
    • A61M29/00A61M2025/0042
    • A catheter for providing an embolic material at a desired location comprises a flexible tubular member having a proximal end and a distal end, the tubular member including at least one ring of expansible material affixed to its outer surface less than 25 mm from the distal end. The ring preferably comprises a material that expands in volume when in contact with a liquid, such as a hydrogel or hydrogel foam, or in response to an application of heat. The ring is fully expanded after between 10 and 30 minutes of contact with a liquid. The catheter may also include further including a plurality of radioopaque markers spaced along the tubular member at predetermined intervals.
    • 用于在期望位置提供栓塞材料的导管包括具有近端和远端的柔性管状构件,所述管状构件包括固定到其远端距离远端25mm的外表面的至少一个可膨胀材料环。 环优选地包括当与液体例如水凝胶或水凝胶泡沫接触时或响应于加热而膨胀的材料。 在与液体接触10至30分钟之后,环完全膨胀。 导管还可以包括进一步包括多个不规则间隔的沿着管状构件间隔开的不透射线标记。
    • 6. 发明申请
    • Microcatheter including swellable tip
    • 微导管包括可膨胀的尖端
    • US20080208160A9
    • 2008-08-28
    • US10755249
    • 2004-01-12
    • Michel Mawad
    • Michel Mawad
    • A61M31/00
    • A61M29/00A61M2025/0042
    • A catheter for providing an embolic material at a desired location comprises a flexible tubular member having a proximal end and a distal end, the tubular member including at least one ring of expansible material affixed to its outer surface less than 25 mm from the distal end. The ring preferably comprises a material that expands in volume when in contact with a liquid, such as a hydrogel or hydrogel foam, or in response to an application of heat. The ring is fully expanded after between 10 and 30 minutes of contact with a liquid. The catheter may also include further including a plurality of radioopaque markers spaced along the tubular member at predetermined intervals.
    • 用于在期望位置提供栓塞材料的导管包括具有近端和远端的柔性管状构件,所述管状构件包括固定到其远端距离远端25mm的外表面的至少一个可膨胀材料环。 环优选地包括当与液体例如水凝胶或水凝胶泡沫接触时或响应于加热而膨胀的材料。 在与液体接触10至30分钟之后,环完全膨胀。 导管还可以包括进一步包括多个不规则间隔的沿着管状构件间隔开的不透射线标记。